Programmed Death-Ligand 1, C-reactive Protein, and Neutrophil/Lymphocyte Ratio as Lymphangiogenesis Markers of Metastasis in Penile Cancer – A Systematic Review

[1] Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49. SungH FerlayJ SiegelRL LaversanneM SoerjomataramI JemalA Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries CA Cancer J Clin. 2021 71 3 209 49 Search in Google Scholar

[2] Fu L, Tian T, Yao K, Chen XF, Luo G, Gao Y, et al. Global Pattern and Trends in Penile Cancer Incidence: Population-Based Study. JMIR Public Heal Surveill. 2022;8(7):e34874. FuL TianT YaoK ChenXF LuoG GaoY Global Pattern and Trends in Penile Cancer Incidence: Population-Based Study JMIR Public Heal Surveill. 2022 8 7 e34874 Search in Google Scholar

[3] Kane C, Sellers L, Miller R. Diagnosis and management of penile cancer. Trends Urol Men's Heal. 2016;7(5):17–20. KaneC SellersL MillerR. Diagnosis and management of penile cancer Trends Urol Men's Heal. 2016 7 5 17 20 Search in Google Scholar

[4] Jakobsen JK, Sørensen CM, Krarup KP, Jensen JB. Quality of life, voiding and sexual function of penile cancer patients: DaPeCa-10—a cross-sectional questionnaire survey. BJUI Compass. 2022;3(5):354–62. JakobsenJK SørensenCM KrarupKP JensenJB. Quality of life, voiding and sexual function of penile cancer patients: DaPeCa-10—a cross-sectional questionnaire survey BJUI Compass. 2022 3 5 354 62 Search in Google Scholar

[5] Harju E, Pakarainen T, Vasarainen H, Törnävä M, Helminen M, Perttilä I, et al. Health-Related Quality of Life, Self-esteem and Sexual Functioning Among Patients Operated for Penile Cancer – A Cross-sectional Study. J Sex Med. 2021;18(9):1524–31. HarjuE PakarainenT VasarainenH TörnäväM HelminenM PerttiläI Health-Related Quality of Life, Self-esteem and Sexual Functioning Among Patients Operated for Penile Cancer – A Cross-sectional Study J Sex Med. 2021 18 9 1524 31 Search in Google Scholar

[6] Bloom JB, Stern M, Patel NH, Zhang M, Phillips JL. Detection of lymph node metastases in penile cancer. Transl Androl Urol. 2018;7(5):879–86. BloomJB SternM PatelNH ZhangM PhillipsJL. Detection of lymph node metastases in penile cancer Transl Androl Urol. 2018 7 5 879 86 Search in Google Scholar

[7] Hu J, Cui Y, Liu P, Zhou X, Ren W, Chen J, et al. Predictors of inguinal lymph node metastasis in penile cancer patients: a meta-analysis of retrospective studies. Cancer Manag Res. 2019;11:6425–41. HuJ CuiY LiuP ZhouX RenW ChenJ Predictors of inguinal lymph node metastasis in penile cancer patients: a meta-analysis of retrospective studies Cancer Manag Res. 2019 11 6425 41 Search in Google Scholar

[8] Chalya PL, Rambau PF, Masalu N, Simbila S. Ten-year surgical experiences with penile cancer at a tertiary care hospital in northwestern Tanzania: A retrospective study of 236 patients. World J Surg Oncol. 2015;13:71. ChalyaPL RambauPF MasaluN SimbilaS. Ten-year surgical experiences with penile cancer at a tertiary care hospital in northwestern Tanzania: A retrospective study of 236 patients World J Surg Oncol. 2015 13 71 Search in Google Scholar

[9] Zekan DS, Dahman A, Hajiran AJ, Luchey AM, Chahoud J, Spiess PE. Prognostic predictors of lymph node metastasis in penile cancer: a systematic review. Int Braz J Urol. 2021;47:943–56. ZekanDS DahmanA HajiranAJ LucheyAM ChahoudJ SpiessPE. Prognostic predictors of lymph node metastasis in penile cancer: a systematic review Int Braz J Urol. 2021 47 943 56 Search in Google Scholar

[10] Zargar-Shostari K, Sharma P, Spiess PE. Insight into novel biomarkers in penile cancer: Redefining the present and future treatment paradigm? Urol Oncol Semin Orig Investig. 2017;1–7. Zargar-ShostariK SharmaP SpiessPE. Insight into novel biomarkers in penile cancer: Redefining the present and future treatment paradigm? Urol Oncol Semin Orig Investig. 2017 1 7 Search in Google Scholar

[11] Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009;6(7):e1000097. MoherD LiberatiA TetzlaffJ AltmanDG. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement PLoS Med. 2009 6 7 e1000097 Search in Google Scholar

[12] De Bacco MW, Carvalhal GF, MacGregor B, Marçal JMB, Wagner MB, Sonpavde GP, et al. PD-L1 and p16 Expression in Penile Squamous Cell Carcinoma From an Endemic Region. Clin Genitourin Cancer [Internet]. 2020;18(3):e254–9. Available from: https://doi.org/10.1016/j.clgc.2019.10.014 De BaccoMW CarvalhalGF MacGregorB MarçalJMB WagnerMB SonpavdeGP PD-L1 and p16 Expression in Penile Squamous Cell Carcinoma From an Endemic Region Clin Genitourin Cancer [Internet]. 2020 18 3 e254 9 Available from: https://doi.org/10.1016/j.clgc.2019.10.014 Search in Google Scholar

[13] Udager A, Liu T, Skala S, Magers M, McDaniel A, Spratt D, et al. Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches. Ann Oncol. 2016;27(9):1706–12. UdagerA LiuT SkalaS MagersM McDanielA SprattD Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches Ann Oncol. 2016 27 9 1706 12 Search in Google Scholar

[14] Ottenhof SR, Djajadiningrat RS, Thygesen HH, Jakobs PJ, Józwiak K, Heeren AM, et al. The prognostic value of immune factors in the tumor microenvironment of penile squamous cell carcinoma. Front Immunol. 2018;9:1253. OttenhofSR DjajadiningratRS ThygesenHH JakobsPJ JózwiakK HeerenAM The prognostic value of immune factors in the tumor microenvironment of penile squamous cell carcinoma Front Immunol. 2018 9 1253 Search in Google Scholar

[15] Hu J, Li H, He T, Deng H, Gong G, Cui Y, et al. A nomogram incorporating PD-L1, NLR, and clinicopathologic features to predict inguinal lymph node metastasis in penile squamous cell carcinoma. Urol Oncol Semin Orig Investig. 2020;38(7):641.e19-641.e29. HuJ LiH HeT DengH GongG CuiY A nomogram incorporating PD-L1, NLR, and clinicopathologic features to predict inguinal lymph node metastasis in penile squamous cell carcinoma Urol Oncol Semin Orig Investig. 2020 38 7 641.e19 641.e29 Search in Google Scholar

[16] Steffens S, Al Ghazal A, Steinestel J, Lehmann R, Wegener G, Schnoeller TJ, et al. High CRP values predict poor survival in patients with penile cancer. BMC Cancer. 2013;13:223. SteffensS Al GhazalA SteinestelJ LehmannR WegenerG SchnoellerTJ High CRP values predict poor survival in patients with penile cancer BMC Cancer. 2013 13 223 Search in Google Scholar

[17] Al Ghazal A, Steffens S, Steinestel J, Lehmann R, Schnoeller TJ, Schulte-Hostede A, et al. Elevated C-reactive protein values predict nodal metastasis in patients with penile cancer. BMC Urol. 2013;13:53. Al GhazalA SteffensS SteinestelJ LehmannR SchnoellerTJ Schulte-HostedeA Elevated C-reactive protein values predict nodal metastasis in patients with penile cancer BMC Urol. 2013 13 53 Search in Google Scholar

[18] Jindal T, Pawar P, Agarwal S, Jain P, Meena M, Sarwal A, et al. The use of preoperative neutrophillymphocyte ratio and lymphocyte-monocyte ratio in predicting survival and groin node involvement of patients with squamous cell carcinoma of penis. Urol Ann. 2021;13(4):391–6. JindalT PawarP AgarwalS JainP MeenaM SarwalA The use of preoperative neutrophillymphocyte ratio and lymphocyte-monocyte ratio in predicting survival and groin node involvement of patients with squamous cell carcinoma of penis Urol Ann. 2021 13 4 391 6 Search in Google Scholar

[19] Protzel C, Knoedel J, Zimmermann U, Woenckhaus C, Poetsch M, Giebel J. Expression of proliferation marker Ki67 correlates to occurrence of metastasis and prognosis, histological subtypes and HPV DNA detection in penile carcinomas. Histol Histopathol. 2007;22(10-12):1197–204. ProtzelC KnoedelJ ZimmermannU WoenckhausC PoetschM GiebelJ. Expression of proliferation marker Ki67 correlates to occurrence of metastasis and prognosis, histological subtypes and HPV DNA detection in penile carcinomas Histol Histopathol. 2007 22 10-12 1197 204 Search in Google Scholar

[20] Cocks M, Taheri D, Ball MW, Bezerra SM, Del Carmen Rodriguez M, Ricardo BFP, et al. Immune-checkpoint status in penile squamous cell carcinoma: A North American Cohort. Hum Pathol. 2017;59:55–61. CocksM TaheriD BallMW BezerraSM Del Carmen RodriguezM RicardoBFP Immune-checkpoint status in penile squamous cell carcinoma: A North American Cohort Hum Pathol. 2017 59 55 61 Search in Google Scholar

[21] Mo M, Li Y, Hu X. Serum CXCL5 level is associated with tumor progression in penile cancer. Biosci Reports. 2021;41(1):BSR20202133. MoM LiY HuX. Serum CXCL5 level is associated with tumor progression in penile cancer Biosci Reports. 2021 41 1 BSR20202133 Search in Google Scholar

[22] Mo M, Tong S, Li T, Zu X, Hu X. Serum CXCL13 Level is Associated with Tumor Progression in Penile Cancer. Onco Targets Ther. 2020;13:8757–69. MoM TongS LiT ZuX HuX. Serum CXCL13 Level is Associated with Tumor Progression in Penile Cancer Onco Targets Ther. 2020 13 8757 69 Search in Google Scholar

[23] Mo M, Tong S, Huang W, Cai Y, Zu X, Hu X. High serum CCL20 is associated with tumor progression in penile cancer. J Cancer. 2020;11(23):6812–22. MoM TongS HuangW CaiY ZuX HuX. High serum CCL20 is associated with tumor progression in penile cancer J Cancer. 2020 11 23 6812 22 Search in Google Scholar

[24] Murta CB, Furuya TK, Carrasco AGM, Uno M, Sichero L, Villa LL, et al. miRNA and mRNA Expression Profiles Associated with Lymph Node Metastasis and Prognosis in Penile Carcinoma. Int J Mol Sci. 2022;23:7103. MurtaCB FuruyaTK CarrascoAGM UnoM SicheroL VillaLL miRNA and mRNA Expression Profiles Associated with Lymph Node Metastasis and Prognosis in Penile Carcinoma Int J Mol Sci. 2022 23 7103 Search in Google Scholar

[25] Ayoubian H, Heinzelmann J, Hölters S, Khalmurzaev O, Pryalukhin A, Loertzer P, et al. miRNA Expression Characterizes Histological Subtypes and Metastasis in Penile Squamous Cell Carcinoma. Cancers (Basel). 2021;13(6):1480. AyoubianH HeinzelmannJ HöltersS KhalmurzaevO PryalukhinA LoertzerP miRNA Expression Characterizes Histological Subtypes and Metastasis in Penile Squamous Cell Carcinoma Cancers (Basel). 2021 13 6 1480 Search in Google Scholar

[26] Mohr T, Zwick A, Hans MC, Bley IA, Braun FL, Khalmurzaev O, et al. The prominent role of the S100A8/S100A9-CD147 axis in the progression of penile cancer. Front Oncol. 2022;12(October):1–14. MohrT ZwickA HansMC BleyIA BraunFL KhalmurzaevO The prominent role of the S100A8/S100A9-CD147 axis in the progression of penile cancer Front Oncol. 2022 12 October 1 14 Search in Google Scholar

[27] van der Fels CAM, Palthe S, Buikema H, van den Heuvel MC, Leliveld A, de Jong IJ. Potential receptors for targeted imaging of lymph node metastases in penile cancer. Diagnostics. 2020;10(9). van der FelsCAM PaltheS BuikemaH van den HeuvelMC LeliveldA de JongIJ. Potential receptors for targeted imaging of lymph node metastases in penile cancer Diagnostics. 2020 10 9 Search in Google Scholar

[28] Zhou QH, Deng CZ, Chen JP, Huang KB, Liu TY, Yao K, et al. Elevated serum LAMC2 is associated with lymph node metastasis and predicts poor prognosis in penile squamous cell carcinoma. Cancer Manag Res. 2018;10:2983–95. ZhouQH DengCZ ChenJP HuangKB LiuTY YaoK Elevated serum LAMC2 is associated with lymph node metastasis and predicts poor prognosis in penile squamous cell carcinoma Cancer Manag Res. 2018 10 2983 95 Search in Google Scholar

[29] Fenner F, Goody D, Protzel C, Erbersdobler A, Richter C, Hartz JM, et al. E2F1 Signalling is Predictive of Chemoresistance and Lymphogenic Metastasis in Penile Cancer: A Pilot Functional Study Reveals New Prognostic Biomarkers. Eur Urol Focus. 2018;4(4):599–607. FennerF GoodyD ProtzelC ErbersdoblerA RichterC HartzJM E2F1 Signalling is Predictive of Chemoresistance and Lymphogenic Metastasis in Penile Cancer: A Pilot Functional Study Reveals New Prognostic Biomarkers Eur Urol Focus. 2018 4 4 599 607 Search in Google Scholar

[30] Zhu Y, Zhou XY, Yao XD, Zhang SL, Dai B, Zhang HL, et al. Prognostic value of carbonic anhydrase IX expression in penile squamous cell carcinoma: A pilot study. Urol Oncol Semin Orig Investig. 2013;31(5):706–11. ZhuY ZhouXY YaoXD ZhangSL DaiB ZhangHL Prognostic value of carbonic anhydrase IX expression in penile squamous cell carcinoma: A pilot study Urol Oncol Semin Orig Investig. 2013 31 5 706 11 Search in Google Scholar

[31] Minardi D, D’Anzeo G, Lucarini G, Filosa A, Zizzi A, Simonetti O, et al. D2-40 immunoreactivity in penile squamous cell carcinoma: A marker of aggressiveness. Hum Pathol. 2011;42(11):1596–602. MinardiD D’AnzeoG LucariniG FilosaA ZizziA SimonettiO D2-40 immunoreactivity in penile squamous cell carcinoma: A marker of aggressiveness Hum Pathol. 2011 42 11 1596 602 Search in Google Scholar

[32] Protzel C, Richter M, Poetsch M, Kakies C, Zimmermann U, Woenckhaus C, et al. The role of annexins I, II and IV in tumor development, progression and metastasis of human penile squamous cell carcinomas. World J Urol. 2011;29(3):393–8. ProtzelC RichterM PoetschM KakiesC ZimmermannU WoenckhausC The role of annexins I, II and IV in tumor development, progression and metastasis of human penile squamous cell carcinomas World J Urol. 2011 29 3 393 8 Search in Google Scholar

[33] Han Y, Liu D, Li L. PD-1/PD-L1 pathway: current researches in cancer. Am J Cancer Res. 2020;10(3):727–42. HanY LiuD LiL. PD-1/PD-L1 pathway: current researches in cancer Am J Cancer Res. 2020 10 3 727 42 Search in Google Scholar

[34] Sanmamed MF, Chen L. A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization. Cell. 2018;175(2):313–26. SanmamedMF ChenL. A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization Cell. 2018 175 2 313 26 Search in Google Scholar

[35] Davidsson S, Carlsson J, Giunchi F, Harlow A, Kirrander P, Rider J, et al. PD-L1 Expression in Men with Penile Cancer and its Association with Clinical Outcomes. Eur Urol Oncol. 2019;2(2):214–21. DavidssonS CarlssonJ GiunchiF HarlowA KirranderP RiderJ PD-L1 Expression in Men with Penile Cancer and its Association with Clinical Outcomes Eur Urol Oncol. 2019 2 2 214 21 Search in Google Scholar

[36] Hart PC, Rajab IM, Alebraheem M, Potempa LA. C-Reactive Protein and Cancer—Diagnostic and Therapeutic Insights. Front Immunol. 2020;11:595835. HartPC RajabIM AlebraheemM PotempaLA. C-Reactive Protein and Cancer—Diagnostic and Therapeutic Insights Front Immunol. 2020 11 595835 Search in Google Scholar

[37] Buonacera A, Stancanelli B, Colaci M, Malatino L. Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases. Int J Mol Sci. 2022;23(7):3636. BuonaceraA StancanelliB ColaciM MalatinoL. Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases Int J Mol Sci. 2022 23 7 3636 Search in Google Scholar